Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate (Q73389491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

S Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

X Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Fisher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J G Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

F Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T W Tobery

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J B Ulmer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R K Evans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M J Caulfield

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1227-1235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

Heterologous protection against influenza by injection of DNA encoding a viral protein

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

1 reference

7 January 2021

DNA vaccines -- a modern gimmick or a boon to vaccinology?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

DNA immunization against experimental genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Liposome-mediated DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Enhancement of DNA vaccine potency using conventional aluminum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

In vivo absorption of aluminium-containing vaccine adjuvants using 26Al

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

A computer program for the evaluation of ELISA data obtained using an automated microtiter plate absorbance reader

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Induction of TH1 and TH2 immunity in neonatal mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Rapid effector function in CD8+ memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Adjuvant Effects of Amorphous Silica and of Aluminium Hydroxide on IgE and IgG<sub>1</sub> Antibody Production in Different Inbred Mouse Strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Studies on antibody production. III. The alum granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Current status of immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900391-6

7 January 2021

10.1016/S0264-410X(99)00391-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10649624%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference